What is Murae Organisor share price return in the past 10 years?

Data is not available for this company

Murae Organisor Ltd - Stock Valuation and Financial Performance

Name: Murae Organisor
Brand: Murae Organisor

BSE: 542724 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Murae Organisor Share Price

₹1.63 -0.03 -1.81%
as on 26-Apr'24 16:01

DeciZen - make an informed investing decision on Murae Organisor

Based on:

Data

M-Cap below 100cr DeciZen not available

Murae Organisor stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

40.3 Cr.

52-wk low:

0.9

52-wk high:

3.1

Is Murae Organisor Ltd an attractive stock to invest in?

1. Is Murae Organisor Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Murae Organisor Ltd is a below average quality company.

2. Is Murae Organisor Ltd undervalued or overvalued?

The key valuation ratios of Murae Organisor Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Murae Organisor Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Murae Organisor Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Murae Organisor:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	11.6%	14.7%	17.9%	17.4%	12.7%	3%	8.9%	8.3%	-
Value Creation Index ⓘ	-0.2	0.1	0.3	0.2	-0.1	-0.8	-0.4	-0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	18.6	23.3	35.4	50.7	55.1	41.1	21	14.1	4
Sales YoY Gr.	-	25.7%	51.8%	43.1%	8.7%	-25.5%	-48.8%	-33%	-
Adj EPS ⓘ	0.1	0.1	0.2	0.3	0.3	0	0.3	0.3	-0
YoY Gr.	-	33.3%	125%	83.3%	-24.2%	-96%	3000%	-12.9%	-
BVPS (₹) ⓘ	0.8	0.9	0.9	1.2	2	2	2.3	2.6	2.2
Adj Net Profit ⓘ	0.1	0.1	0.9	1.7	1.8	0.1	2.2	2	-1
Cash Flow from Ops. ⓘ	-0.3	0.1	-7.1	-0.5	-3.5	-7.1	2.6	0.3	-
Debt/CF from Ops. ⓘ	-7.2	24.1	-1	-20	-2.7	-1.6	3.4	33.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-16.9%	-36.5%	-33%
Adj EPS ⓘ	NA	8.5%	2.6%	-12.9%
BVPSⓘ	NA	24.4%	9.1%	11.8%
Share Price	-	-	-34.2%	-25.2%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	7.4	9.9	28	30.8	17.9	0.6	14.3	11.2	-1.3
Op. Profit Mgn % ⓘ	2.8	1.7	4.4	6.5	2.3	-18.9	-21	6.6	-8.7
Net Profit Mgn % ⓘ	0.6	0.6	2.5	3.3	3.3	0.2	10.6	14.1	-18.2
Debt to Equity ⓘ	1.4	1.4	1.7	1.6	0.6	0.8	0.5	0.5	-
Working Cap Days ⓘ	0	149	155	151	182	264	479	728	3,558
Cash Conv. Cycle ⓘ	0	71	89	96	112	205	443	628	3,106

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 0.47

Return on Equity is Poor

Sales growth has been subdued in last 3 years -36.53%

Sales growth is not so good in last 4 quarters at -71.88%

Latest Financials - Murae Organisor Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-0	-
TTM Sales (₹ Cr.)	4.1	-
BVPS (₹.) ⓘ	2.2	-
Reserves (₹ Cr.) ⓘ	5	-
P/BV ⓘ	0.74	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.90 / 3.10
All Time Low / High (₹)	0.90 / 22.31
Market Cap (₹ Cr.)	40.3
Equity (₹ Cr.)	49.4
Face Value (₹)	2
Industry PE ⓘ	48.8

Management X-Ray of Murae Organisor:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Murae Organisor

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Murae Organisor

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	18.57	23.34	35.44	50.70	55.11	41.08	21.04	14.09
Operating Expenses ⓘ	18.05	22.94	33.88	47.40	53.87	48.84	25.46	13.17
Manufacturing Costs	0.05	0.09	0.09	0.10	0.33	0.02	0.03	0.12
Material Costs	16.91	22.01	33.18	46.22	50.36	46.27	25.04	12.22
Employee Cost	0.40	0.30	0.10	0.19	0.30	0.29	0.04	0.08
Other Costs ⓘ	0.68	0.54	0.52	0.89	2.88	2.25	0.35	0.75
Operating Profit ⓘ	0.52	0.40	1.55	3.30	1.24	-7.76	-4.42	0.93
Operating Profit Margin (%)	2.8%	1.7%	4.4%	6.5%	2.2%	-18.9%	-21.0%	6.6%
Other Income ⓘ	0.06	0.38	0.43	0.05	2.27	8.93	7.70	2.26
Interest ⓘ	0.40	0.52	0.72	1.04	0.97	0.93	0.08	0.29
Depreciation ⓘ	0.02	0.02	0.02	0.04	0.10	0.12	0.12	0.10
Exceptional Items ⓘ	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.16	0.24	1.24	2.28	2.45	0.12	3.08	2.80
Tax ⓘ	0.06	0.08	0.33	0.62	0.63	0.03	0.86	0.81
Profit After Tax	0.10	0.16	0.91	1.66	1.82	0.09	2.22	1.98
PAT Margin (%)	0.5%	0.7%	2.6%	3.3%	3.3%	0.2%	10.6%	14.1%
Adjusted EPS (₹)	0.0	0.1	0.2	0.3	0.3	0.0	0.3	0.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	1.37	1.53	4.38	5.94	14.41	14.50	16.73	18.71
Share Capital ⓘ	0.11	0.11	0.31	0.31	6.17	6.17	12.34	12.34
Reserves ⓘ	1.26	1.42	4.08	5.64	8.25	8.33	4.39	6.37
Minority Interest	0	0	0	0	0	0	0	0
Debt	1.90	2.06	6.53	8.33	8.44	11.33	8.74	8.74
Long Term Debt	0.39	0.56	1.49	2.59	1.37	2.38	0	0
Short Term Debt	1.51	1.50	5.04	5.74	7.07	8.95	8.74	8.74
Trade Payables	4.97	4.99	7.01	6.82	11.51	1.29	1.21	-0.85
Others Liabilities ⓘ	0.55	2.51	1.59	2.16	1.80	0.74	2.12	1.99
Total Liabilities ⓘ	8.79	11.08	19.51	23.26	36.16	27.87	28.79	28.58
Fixed Assets
Gross Block	0.19	0.21	0.26	0.58	1	1.02	0.95	0.95
Accumulated Depreciation	0.02	0.05	0.07	0.11	0.21	0.26	0.37	0.48
Net Fixed Assetsⓘ	0.17	0.16	0.20	0.48	0.80	0.76	0.58	0.48
CWIP ⓘ	0	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	3.03	0	0	0
Inventories	3.61	6.54	8.29	10.93	13.39	15.46	12.25	13.13
Trade Receivables	4.45	3.58	10.79	10.85	16.95	10.67	15.04	8.39
Cash Equivalents	0.36	0.18	0.02	0.16	0.03	0.06	0.05	0.03
Others Assetsⓘ	0.20	0.62	0.21	0.84	1.96	0.91	0.87	6.56
Total Assets ⓘ	8.79	11.08	19.51	23.26	36.16	27.87	28.79	28.58

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	-0.26	0.09	-7.09	-0.48	-3.45	-7.10	2.61	0.26
PBT ⓘ	0.16	0.24	1.24	2.28	2.45	0.12	3.08	2.80
Adjustment ⓘ	0.41	0.43	0.01	1.08	1.07	1.05	0.20	0.39
Changes in Working Capital ⓘ	-0.77	-0.51	-8.02	-2.18	-5.36	-7.31	0.18	-2.11
Tax Paid ⓘ	-0.06	-0.08	-0.32	-0.62	-0.63	-0.03	-0.86	-0.81
Cash Flow From Investing Activity ⓘ	-0.15	-0.02	-0.05	-0.32	-3.45	2.94	0.06	0
Capex	-0.15	-0.02	-0.06	-0.32	-0.42	-0.09	0.06	0
Net Investments	0	0	0.01	0	-3.03	0	0	0
Others ⓘ	0	0	0	0	0	3.03	0	0
Cash Flow From Financing Activityⓘ	0.77	-0.25	6.98	0.94	6.76	2.90	-2.67	-0.29
Net Proceeds from Shares ⓘ	0.40	0	1.93	-0.10	6.65	0	0	0
Net Proceeds from Borrowing ⓘ	0.75	0.17	0.97	0.87	-1.22	1.01	-2.38	0
Interest Paid ⓘ	-0.38	-0.41	0	0	0	0	-0.08	-0.29
Dividend Paid ⓘ	0	0	0	0	0	0	0	0
Others ⓘ	0	-0.01	4.07	0.17	1.33	1.89	-0.21	0
Net Cash Flow ⓘ	0.35	-0.18	-0.16	0.14	-0.14	-1.26	-0.01	-0.03

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	7.15	11.05	30.94	32.17	17.83	0.61	14.24	11.18
ROCE (%)	17.1	21.97	24.94	23.99	17.4	4.23	12.34	11.66
Asset Turnover Ratio	2.11	2.35	2.32	2.37	1.86	1.28	0.74	0.49
PAT to CFO Conversion(x)	-2.6	0.56	-7.79	-0.29	-1.9	-78.89	1.18	0.13
Working Capital Days
Receivable Days	88	63	74	78	92	123	223	303
Inventory Days	71	79	76	69	81	128	240	329
Payable Days	107	83	66	55	66	51	18	5

Murae Organisor Ltd Stock News

Murae Organisor Ltd FAQs

What is the share price of Murae Organisor?

Company share prices are keep on changing according to the market conditions. The closing price of Murae Organisor on 26-Apr-2024 16:01 is ₹1.63.

What is the market cap of Murae Organisor?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 26-Apr-2024 16:01 the market cap of Murae Organisor stood at ₹40.28.

What is the P/E ratio of Murae Organisor?

The latest P/E ratio of Murae Organisor as of 26-Apr-2024 16:01 is 0.00.

What is the P/B ratio of Murae Organisor?

The latest P/B ratio of Murae Organisor as of 26-Apr-2024 16:01 is 0.74.

What is the 52-week high and low of Murae Organisor?

The 52-week high of Murae Organisor is ₹3.10 and the 52-week low is ₹0.90.

What is the TTM revenue of Murae Organisor?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Murae Organisor is ₹4.08 ( Cr.) .

About Murae Organisor Ltd

Earum Pharmaceuticals

Earum Pharmaceuticals was originally incorporated as 'Earum Pharmaceuticals Private Limited' on July 26, 2012 vide Registration no. 071299 under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Further, pursuant to Special Resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 10, 2019, the company was converted into a Public Limited Company and consequently the name of the Company was changed from 'Earum Pharmaceuticals Private Limited' to 'Earum Pharmaceuticals Limited' vide a fresh Certificate of Incorporation dated January 23, 2019 issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company post conversion.

Business area of the company

The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API’s) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc.

Milestones:
2012: Incorporation of the Company in the name of 'Earum Pharmaceuticals Private Limited'.
2014-15: Total turnover of the Company reached to Rs. 8 crores.
2015-16: Crossed Turnover of Rs. 18 crores.
2016-17: Crossed Turnover of Rs. 23 crores.
2017-18: Crossed Turnover of Rs. 35 crores.
2019: Conversion of the Company from Private Limited to Public Limited Company.